Deciphering doxorubicin-induced cardiotoxicity:insights at single-cell resolution

17 May 2025 (10:00 - 11:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Jens Van Fraeyenhove

University of Turin, Turin (Italy)

7 More presentations in this session

Presentation thumbnail

Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients

Doctor D. Bursacovschi (Chisinau, MD)

Abstract Slides Video

Presentation thumbnail

Takotsubo syndrome stress induced heart failure syndrome with significant LVOT obstruction

Doctor D. Kutlesic Kurtovic (Nis, RS)

Abstract Slides Video

Presentation thumbnail

Nicotinamide-N-methyltransferase inhibition improves cardiac function and structure in a heart failure with preserved ejection fraction mouse model

Mr S. Li (Groningen, NL)

Abstract Slides Video

Presentation thumbnail

Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study

Doctor D. Faro (Catania, IT)

Abstract Slides Video

Presentation thumbnail

Evaluating systemic vascular resistance in response to stress facilitates identification of heart failure

Professor D. Jakovljevic (Newcastle-Upon-Tyne, GB)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - pathophysiology and mechanisms (2)

The Event

Event poster

Heart Failure 2025

17 May 2025 10:00 CET

You may be interested in

Congress Presentation

Preclinical models

Congress Presentation

The role of TAK1 inhibition in doxorubicin-induced cardiotoxicity: an in vitro study

Congress Presentation

Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources